Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Johnson & Johnson    JNJ   US4781601046

JOHNSON & JOHNSON (JNJ)

188
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 

Johnson & Johnson : J&J Chairman Weldon's Salary Cut To $1 Million After Stepping Down As CEO

05/07/2012 | 05:51pm US/Eastern
Recommend:
0
   By Peter Loftus 
   Of  
 

Johnson & Johnson (JNJ) Chairman William Weldon's annual base salary was reduced by nearly half to $1 million after he stepped down as chief executive last month, the company said Monday.

Weldon's previous annual base salary was set at $1.97 million for 2012, for his roles as both chairman and CEO, but with the expectation that J&J's board would consider the appropriate compensation for Weldon in his role as chairman only.

The decrease reflects that Weldon is no longer CEO, said spokesman Al Wasilewski.

On April 26, Alex Gorsky succeeded Weldon as CEO. Weldon is continuing as chairman and will remain an employee of the company, J&J said in a quarterly report filed with the Securities and Exchange Commission Monday.

J&J said in a previous SEC filing that in his role as chairman, Weldon will work closely with Gorsky to ensure a seamless leadership transition. During this time, all day-to-day management and operational responsibilities are being transferred to Gorsky.

Weldon will remain an employee but not a member of the J&J executive committee, which is the principal management group responsible for strategic operations and allocations of the resources of the company.

Weldon's main duties as chairman will include working with the board of directors, facilitating communication between the board and management, assisting Gorsky in business planning and strategy, representing the company before governmental and other organizations, and serving as chairman of the board's finance committee.

-By Peter Loftus, Dow Jones Newswires; +1-215-982-5581; peter.loftus@dowjones.com

Recommend :
0
React to this article
Latest news on JOHNSON & JOHNSON
1h ago Zimmer to buy Biomet for $13.35 billion in latest consolidation
3h ago JOHNSON & JOHNSON : Arkansas court won't reconsider Risperdal case
3h ago JOHNSON & JOHNSON : J&J: Business doing well on new product approvals
5h ago JOHNSON & JOHNSON : Announces Dividend Increase of 6.1%
8h ago JOHNSON & JOHNSON : Federal Court to Hear Arguments in Challenge to Oregon Marri..
12h ago JOHNSON & JOHNSON : Risperdal Breast-Growth Lawyer Help: Resource4thePeople Enco..
1d ago JOHNSON & JOHNSON : Researchers at Johnson & Johnson Have Reported New Data on H..
1d ago JOHNSON & JOHNSON : Kelly Rutherford and Nigel Barker Join Global Moms Relay Par..
1d ago JOHNSON & JOHNSON : to Host Medical Devices & Diagnostics Business Review
1d ago JOHNSON & JOHNSON : Solar power surging in Latin America with World Cup fever
Advertisement
Chart
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | 4-Traders
Income Statement Evolution
Johnson _ Johnson : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF